Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment
This study investigated the spontaneous reversibility of bone loss caused by gonadotropin-releasing hormone analog treatment, finding that bone mineral density partially recovered after cessation of the treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. via openalex
- Bone Mineral Density of the Lumbar Spine in Endometriosis Subjects Compared to an Age-Similar Control Population* via openalex
- Changing concepts of medical treatment of endometriosis via openalex
- Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain via openalex
- Gonadotropin-releasing hormone agonists: Strategies formanaging the hypoestrogenic effects of therapy via openalex
- Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
- Nafarelin therapy in endometriosis: Long-term effects on bone mineral density via openalex
- Reduced Bone Mass in Reproductive-Aged Women with Endometriosis* via openalex
- Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma via openalex
- W2467395168 via openalex
- W2472762831 via openalex
- W6714902491 via openalex
- W1512318310 via openalex
- W1984155944 via openalex
- W1999502490 via openalex
- W2010663321 via openalex
- W2055260481 via openalex
- W2078632549 via openalex
- W2109034857 via openalex
- W2128241866 via openalex
- W2153895111 via openalex
- W2287757320 via openalex
Cited by (25)
- Pharmacokinetic considerations for gonadotropin-releasing hormone agonists and antagonists to treat endometriosis 2025
- The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis 2022
- Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: A meta-analysis 2022
- Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2019
- <p>Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data</p> 2019
- Emerging therapy for endometriosis 2015
- An update on the pharmacological management of endometriosis 2013
- Catamenial Pneumothorax: A Case Report and Review of the Literature 2008
- Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo-controlled, double-blind trial 2006
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- Long-term fracture risk among women with proven endometriosis 2006
- Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain 2006
- Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo-controlled, double-blind trial 2006
- Use of a gonadotropin‐releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus 2005
- Painful menstruation 2005
- Long-term effects on bone mineral density and bone metabolism of 6 months’ treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate 2005
- Prolonged GnRH Agonist and Add-Back Therapy for Symptomatic Endometriosis 2002
- Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone 2002
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up 2000
- Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial 2000
- A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis 2000
- Endometriosis: An Overview of the Disease and Its Treatment 2000
- Medical Treatment of Endometriosis-Associated Pain 1999
- Women of Reproductive Age with Endometriosis are Not Osteopenic 1998
- GnRH agonists and add‐back therapy: is there a perfect combination? 1998
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00